A genome-wide survey of RAS transformation targets
- PMID: 10655059
- DOI: 10.1038/72799
A genome-wide survey of RAS transformation targets
Abstract
An important aspect of multi-step tumorigenesis is the mutational activation of genes of the RAS family, particularly in sporadic cancers of the pancreas, colon, lung and myeloid system. RAS genes encode small GTP-binding proteins that affect gene expression in a global way by acting as major switches in signal transduction processes, coupling extracellular signals with transcription factors. Oncogenic forms of RAS are locked in their active state and transduce signals essential for transformation, angiogenesis, invasion and metastasis via downstream pathways involving the RAF/MEK/ERK cascade of cytoplasmic kinases, the small GTP-binding proteins RAC and RHO, phosphatidylinositol 3-kinase and others. We have used subtractive suppression hybridization (SSH), a PCR-based cDNA subtraction technique, to contrast differential gene expression profiles in immortalized, non-tumorigenic rat embryo fibroblasts and in HRAS- transformed cells. Sequence and expression analysis of more than 1,200 subtracted cDNA fragments revealed transcriptional stimulation or repression of 104 ESTs, 45 novel sequences and 244 known genes in HRAS- transformed cells compared with normal cells. Furthermore, we identified common and distinct targets in cells transformed by mutant HRAS, KRAS and NRAS, as well as 61 putative target genes controlled by the RAF/MEK/ERK pathway in reverted cells treated with the MEK-specific inhibitor PD 98059.
Similar articles
-
Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.Oncogene. 2005 Jan 13;24(3):489-501. doi: 10.1038/sj.onc.1208209. Oncogene. 2005. PMID: 15516973
-
Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.Mol Cancer Res. 2003 Dec;1(14):1077-88. Mol Cancer Res. 2003. PMID: 14707291
-
Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.Oncogene. 2000 Sep 28;19(41):4685-94. doi: 10.1038/sj.onc.1203836. Oncogene. 2000. PMID: 11032018
-
Oncogenic Ras in tumour progression and metastasis.Biol Chem. 2005 Mar;386(3):193-205. doi: 10.1515/BC.2005.025. Biol Chem. 2005. PMID: 15843165 Review.
-
[Ras p21 and signal transduction].Gan To Kagaku Ryoho. 1993 Jun;20(8):1107-21. Gan To Kagaku Ryoho. 1993. PMID: 8512342 Review. Japanese.
Cited by
-
Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment.Int J Mol Sci. 2023 Sep 21;24(18):14403. doi: 10.3390/ijms241814403. Int J Mol Sci. 2023. PMID: 37762707 Free PMC article. Review.
-
Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1.PLoS One. 2023 May 16;18(5):e0285707. doi: 10.1371/journal.pone.0285707. eCollection 2023. PLoS One. 2023. PMID: 37192201 Free PMC article.
-
Design of amino acid- and carbohydrate-based anticancer drugs to inhibit polymerase η.Sci Rep. 2022 Nov 2;12(1):18461. doi: 10.1038/s41598-022-22810-z. Sci Rep. 2022. PMID: 36323739 Free PMC article.
-
Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma.Cancer Manag Res. 2021 Nov 23;13:8781-8794. doi: 10.2147/CMAR.S336265. eCollection 2021. Cancer Manag Res. 2021. PMID: 34849030 Free PMC article. Review.
-
Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial-Mesenchymal Transition.Front Oncol. 2021 Aug 26;11:709486. doi: 10.3389/fonc.2021.709486. eCollection 2021. Front Oncol. 2021. PMID: 34552870 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous